From the Guidelines
Laboratory tests for interstitial lung disease (ILD) should include complete blood count, comprehensive metabolic panel, erythrocyte sedimentation rate, C-reactive protein, antinuclear antibody, rheumatoid factor, anti-cyclic citrullinated peptide antibodies, and anti-neutrophil cytoplasmic antibodies, as recommended by the most recent guidelines 1.
Key Laboratory Tests
- Complete blood count
- Comprehensive metabolic panel
- Erythrocyte sedimentation rate
- C-reactive protein
- Antinuclear antibody
- Rheumatoid factor
- Anti-cyclic citrullinated peptide antibodies
- Anti-neutrophil cytoplasmic antibodies
Additional Specific Tests
- Myositis panel (anti-Jo-1, anti-PL-7, anti-PL-12)
- Anti-Scl-70 and anti-centromere antibodies for scleroderma
- Serum precipitins for hypersensitivity pneumonitis
Pulmonary Function Tests
Pulmonary function tests are essential and typically show restrictive pattern with decreased diffusion capacity, as noted in the guidelines 1.
Arterial Blood Gases
Arterial blood gases may reveal hypoxemia, especially with exertion, which is an important consideration in the diagnosis and management of ILD 1.
Serum Biomarkers
Serum biomarkers like KL-6, SP-A, SP-D, and MMP-7 can help assess disease activity and prognosis, as discussed in the guidelines 1.
Interpretation of Laboratory Findings
Laboratory findings should always be interpreted alongside clinical presentation, imaging studies (particularly high-resolution CT scans), and sometimes lung biopsy results for accurate diagnosis and management of ILD, as recommended by the guidelines 1.
From the Research
Laboratory Tests for Interstitial Lung Disease (ILD)
The following laboratory tests are indicated for ILD:
- Autoantibody testing, including:
- Other laboratory tests, such as:
Imaging Studies for ILD
Imaging studies, including:
- High-resolution computed tomography (HRCT) of the thorax 3
Diagnostic Evaluation for ILD
A diagnostic evaluation for ILD should include: